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Abstract
Background: Melioidosis, caused by infection with Burkholderia (B.) pseudomallei, is a severe illness that is endemic in
Southeast Asia. Osteopontin (OPN) is a phosphorylated glycoprotein that is involved in several immune responses including
induction of T-helper 1 cytokines and recruitment of inflammatory cells.
Methodology and Principal Findings: OPN levels were determined in plasma from 33 melioidosis patients and 31 healthy
controls, and in wild-type (WT) mice intranasally infected with B. pseudomallei. OPN function was studied in experimental
murine melioidosis using WT and OPN knockout (KO) mice. Plasma OPN levels were elevated in patients with severe
melioidosis, even more so in patients who went on to die. In patients who recovered plasma OPN concentrations had
decreased after treatment. In experimental melioidosis in mice plasma and pulmonary OPN levels were also increased.
Whereas WT and OPN KO mice were indistinguishable during the first 24 hours after infection, after 72 hours OPN KO mice
demonstrated reduced bacterial numbers in their lungs, diminished pulmonary tissue injury, especially due to less necrosis,
and decreased neutrophil infiltration. Moreover, OPN KO mice displayed a delayed mortality as compared to WT mice. OPN
deficiency did not influence the induction of proinflammatory cytokines.
Conclusions: These data suggest that sustained production of OPN impairs host defense during established septic
melioidosis.
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Introduction
Melioidosis is an important cause of severe sepsis in Southeast
Asia and Northern Australia caused by the aerobic gram-negative
soil-dwelling bacillus Burkholderia (B.) pseudomallei [1,2]. Infection is
thought to occur by cutaneous inoculation or inhalation. More
than half of patients with melioidosis present with pneumonia
associated with bacterial dissemination to distant organs [3], and
all-cause mortality is as high as 50% in Northeast Thailand where
the majority of reported cases occur [4].
B. pseudomallei is a facultative intracellular pathogen that multiplies
in the host cell cytosol [5,6]. Although the pathogenesis of melioidosis
is still largely unknown, both innate and adaptive responses are
important for an adequate host response [7]. Patients with severe
melioidosis demonstrate elevated serum concentrations of several
cytokines, including the T-helper (Th) 1 cytokines interferon (INF)-c
and interleukin (IL)-12 and IL-18 [8,9]. Murine studies on the
functional role of these cytokines and on tumor necrosis factor (TNF)-
a during experimental melioidosis have shown enhanced mortality
and bacterial outgrowth when one of these mediators was absent or
inhibited, demonstrating the importance of these cytokines for host
defense against B. pseudomallei [9–11]. Moreover, accumulating data
show a vital role for neutrophils and macrophages in the host
response to this pathogen [12–17].
Osteopontin (OPN) is a phosphorylated glycoprotein expressed
by a broad range of tissues and cells that is involved in a number of
physiological and pathological processes. OPN has been implicated
in the regulation of inflammation; OPN acts as a chemotactic factor
for T-cells, macrophages and neutrophils and modulates the
function and differentiation of these inflammatory cells [18–23].
Several in vitro and in vivo studies indicate that OPN stimulates Th1
responses by inducing IL-12 and IFN-c [24–27]. A recent report of
elevated circulating OPN levels in patients with severe sepsis and
septic shock further implicated this mediator in the pathogenesis of
severe bacterial infection [28]. The contribution of OPN to the host
response to bacterial infection has only been studied to a limited
www.plosntds.org 1 August 2010 | Volume 4 | Issue 8 | e806extent [29,30]. Here, we sought to investigate the function of OPN
in sepsiscausedby melioidosis. Forthis wedetermined OPNplasma
levels in patients with severe melioidosis and studied the role of
OPN using an established model of murine melioidosis [17,31].
Methods
Ethics statement
The patient study was approved by both the Ministry of Public
Health, Royal Government of Thailand and the Oxford Tropical
Research Ethics Committee, University of Oxford, England. We
obtained written informed consent from all subjects before the
study. The Animal Care and Use Committee of the University of
Amsterdam approved all animal experiments.
Patients
We included 33 individuals with sepsis caused by B. pseudomallei
and 31 healthy controls in this study. Individuals were recruited
prospectively at Sapprasithiprasong Hospital, Ubon Ratchathani,
Thailand in 2004. Sepsis due to melioidosis was defined as culture
positivity for B. pseudomallei from any clinical sample plus a systemic
inflammatory response syndrome (SIRS). To meet the SIRS
criteria patients had to have at least three of the following four
criteria: a core temperature of $38uCo r#36uC; a heart rate of
$90 beats/min; a respiratory rate of $20 breaths/min or a
PaCO2 of $32 mmHg or the use of mechanical ventilation for an
acute respiratory process; a white-cell count of $12610
9/l or
#4610
9/l or a differential count showing .10% immature
neutrophils [32]. Study design and subjects have been described in
detail elsewhere [33]. Blood samples for OPN measurements were
drawn in heparin anticoagulated tubes in all subjects (once from
controls and from patients within 36 hours after the initiation of
antibiotic therapy and where possible at the end of intravenous
treatment with antibiotics).
Cell cultures
Stimulation of alveolar macrophages and respiratory epithelial
cells was done as described previously [17]. In brief, the murine
alveolar macrophage cell line MH-S (American Type Culture
Collection; ATCC CRL-2019; Rockville, MD) was grown in
RPMI 1640 (Gibco, Life Technologies, Rockville, MD) containing
2m M L-glutamine, penicillin, streptomycin and 10% fetal calf
serum, supplemented with 50 mM2 - bME (Sigma, Aldrich, St.
Loius, MO). The murine transformed ATII respiratory epithelial
cell line MLE-15 was generously provided by Jeffrey Whitsett
(Cincinnati Children’s Hospital Medical Center, Cincinnati) and
was cultured in HITES medium (RPMI 1640 supplemented to
5 mg/ml insulin, 10 mg/ml transferrin, 30 nM sodium selenite,
10 nM hydrocortisone and 10 nM b-estradiol) supplemented with
2% FCS, penicillin and streptomycin. In vitro stimulation of cell-
lines was conducted in 96-well plates (Greiner, Alphen aan de
Rijn, the Netherlands) at a density of 5610
5 cells/ml. Following
overnight culture at 37uCi n5 %C O 2, adherent cells were washed
twice and then stimulated with heat-killed B. pseudomallei (strain
1026b, kindly provided by Dr. Don Woods, University of Calgary,
Canada, multiplicity of infection 1:10 and 1:100) at 37uCi n5 %
CO2. Supernatants were taken after 4 hours of stimulation and
stored at 220uC until assayed for OPN. Primary alveolar
macrophages were harvested and stimulated as described
previously [33,34].
Mice
Pathogen-free male WT C57BL/6 mice were purchased from
Harlan Sprague Dawley Inc. (Horst, The Netherlands). OPN
knockout (KO) mice, on a C57BL/6 genetic background, were
obtained from the Jackson Laboratories (Bar Harbor, ME) and
bred in the animal facility of the Academic Medical Center
(Amsterdam, The Netherlands).
Study design
Melioidosis was induced by intranasal inoculation of ,10
3
colony forming units (CFU) of B. pseudomallei, strain 1026b in 50 ml
0.9% NaCl, as described previously [17,31]. Mice were sacrificed
after 24 or 72 h (n=8 per group), when blood was drawn into
heparin containing tubes, and organs were removed aseptically
and homogenized in 5 volumes of sterile 0.9% NaCl using a tissue
homogenizer (Biospec Products, Bartlesville, OK). CFUs were
determined from serial dilutions of organ homogenates and blood,
plated on blood agar plates and incubated at 37uCa t5 %C O 2 for
16 h before colonies were counted. For survival studies mice
(n=14 per group) were monitored for 14 days after infection.
Histology
Lungs and livers were harvested 24 and 72 hours after infection,
fixed in 10% buffered formalin for 24 h, and embedded in
paraffin. Hematoxilin and eosin stained slides were coded and
scored from 0 (absent) to 4 (severe) by a pathologist blinded for
groups. For lung the following parameters were scored: interstitial
inflammation, endothelialitis, bronchitis, edema, necrosis and
pleuritis. The total ‘‘lung inflammation score’’ was expressed as the
sum of the scores for each parameter, the maximum being 24.
Confluent (diffuse) inflammatory infiltrate was quantified sepa-
rately and expressed as percentage of the lung surface. For liver
abscess, necrosis and thrombus formation was scored.
Assays
OPN, keratinocyte-derived cytokine (KC), macrophage inflam-
matory protein (MIP)–2, and LPS-induced CXC chemokine (LIX)
were measured by ELISA (R&D Systems, Abingdon, UK). IL-
12p70, IFN-c, TNF-a, IL-6, IL-10 and monocyte chemoattractant
protein (MCP)-1 were measured by cytometric bead array
Author Summary
Melioidosis is a severe tropical disease caused by infection
with the bacterium Burkholderia (B.) pseudomallei.I n
northeast Thailand infection with this bacterium is the
major cause of community-acquired septicemia with a
mortality rate up to 40%. Extending the knowledge on the
mechanisms of host defense against B. pseudomallei
infection would be helpful to improve treatment of this
severe illness. Osteopontin (OPN) is a cytokine that is
involved in several immune responses that occur during
bacterial infection. In this study, we investigated levels of
OPN in patients with melioidosis, and studied the function
of OPN during experimental melioidosis in mice. We found
that OPN concentrations were elevated in patients with
severe melioidosis, and that high OPN concentrations are
associated with poor outcome in patients with melioidosis.
In experimental melioidosis in mice plasma and lung OPN
levels were also increased. Moreover, mice with melioido-
sis that were deficient for OPN demonstrated reduced
bacterial numbers in their lungs, diminished pulmonary
tissue injury, and decreased neutrophil infiltration into the
lungs during established melioidosis. Moreover, these mice
displayed a delayed mortality as compared to control mice.
In conclusion, sustained production of OPN impairs host
defense during melioidosis.
Osteopontin in Melioidosis
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mendations (BD Biosciences, San Jose, CA). Myeloperoxidase
(MPO) was measured by ELISA (Hycult Biotechnology BV, Uden,
The Netherlands). Aspartate aminotransferase (ASAT) and
alanine aminotransferase (ALAT) were determined with commer-
cially available kits (Sigma-Aldrich), using a Hitachi analyzer
(Roche) according to the manufacturer’s instructions.
Statistical analysis
Values are expressed as mean 6 standard error of the mean
(SEM). Differences between groups were analyzed by the Mann-
Whitney U test, preceded by Kruskal-Wallis analysis where
appropriate. Paired patient samples were analyzed using a
Wilcoxon signed rank test. Survival curves were compared by
Kaplan-Meier analysis followed by log-rank test. These analyses
were performed using GraphPad Prism version 4.0, GraphPad
Software (San Diego, CA). Values of P,0.05 were considered
statistically significant.
Results
Elevated plasma osteopontin levels in patients with
culture proven melioidosis
To obtain a first insight into OPN expression during
melioidosis, we measured OPN in plasma from 33 patients with
septic melioidosis and from 31 healthy controls. The mortality rate
in this cohort of patients was 44% [33]. OPN levels were
approximately 70-fold higher in melioidosis patients than in
healthy controls (figure 1A, P,0.001). On admission, patients who
went on to die had higher OPN plasma levels than patients who
survived (figure 1B, P,0.05). Furthermore, in eight patients from
whom a second blood sample was obtained at the end of a two-
week treatment period, plasma OPN levels had dramatically
decreased as compared to levels measured on admission to the
hospital (figure 1C, P,0.01).
Osteopontin levels are increased during murine
melioidosis
To determine whether OPN production is enhanced during
melioidosis in mice, we intranasally infected WT mice with B.
pseudomallei and measured OPN levels in plasma and whole lung
homogenates (figure 2A–B). At 24 h after infection plasma OPN
concentrations were significantly elevated compared to baseline
(P,0.01) and were further increased at 72 h after infection
(P,0.01, figure 2A). The same result was found for lung OPN
levels (P,0.05 and P,0.001 for 24 and 72 h respectively,
figure 2B). To determine whether OPN is released by pulmonary
cells upon stimulation with B. pseudomallei, we incubated murine
alveolar macrophage MHS and lung epithelial MLE-15 cells with
medium or heat-killed B. pseudomallei (MOI 1:10 and 1:100) for
4 h. OPN release by both alveolar macrophages and epithelial
cells was significantly enhanced upon B. pseudomallei stimulation in
a dose dependent manner compared to the medium control
(MHS: P,0.05 for both MOI, MLE-15: P=0.05 for 1:10 and
P,0.05 for 1:100, figure 2C–D).
Osteopontin facilitates pulmonary bacterial growth
To determine whether OPN impacts on bacterial outgrowth
during melioidosis, we determined bacterial loads in lungs from
WT and OPN KO mice. At 24 h after infection bacterial
outgrowth was similar in both groups. At 72 h after infection,
however, bacterial loads were significantly decreased in lungs of
OPN KO as compared to WT mice (figure 3A, P,0.01). To
obtain insights into the dissemination of infection we determined
bacterial loads in blood and spleen. Bacteria were not detectable in
those distinct body sites at 24 h. After 72 h of infection, OPN KO
mice had lower bacterial loads in blood and spleen than WT mice
although the difference did not reach statistical significance
(figure 3B–C).
Osteopontin deficiency does not influence pulmonary
cytokine concentrations
Since cytokines play an important role in host defense against B.
pseudomallei [2] and OPN is known to act as a proinflammatory
mediator able to induce cytokines including IFN-c and IL-12
[24,25], we measured proinflammatory cytokines (IFN-c, IL-
12p70, TNF-a, IL-6), an anti-inflammatory cytokine (IL-10) and
chemokines (KC, MIP-2, LIX and MCP-1) in lung homogenates
obtained 24 and 72 h after infection. With regard to chemokines
we especially focused on neutrophil attracting proteins (i.e. KC,
MIP-2 and LIX) considering that neutrophils are of utmost
importance for host defense against melioidosis [12]. All measured
cytokines and chemokines increased from 24 to 72 h after
infection in both WT and OPN KO mice. Except for KC levels,
which were significantly decreased in OPN KO lungs as compared
to WT at both timepoints, no significant differences between the
two mouse strains were found at either timepoint (table 1). In
accordance with these in vivo data, primary alveolar macrophages
harvested from uninfected WT and OPN KO mice released
similar quantities of TNF-a, IL-6 and MIP-2, but reduced levels of
Figure 1. OPN plasma levels are elevated in patients with melioidosis and correlate with mortality. OPN plasma concentrations in (A)
healthy controls versus melioidosis patients (n=31 and n=33, respectively), (B) survivors versus non-survivors (n=19 and n=14, respectively), and
(C) patients at admission versus follow up sampling (n=8). Data are expressed as means 6 SEM, * P,0.05, ** P,0.01 and *** P,0.001.
doi:10.1371/journal.pntd.0000806.g001
Osteopontin in Melioidosis
www.plosntds.org 3 August 2010 | Volume 4 | Issue 8 | e806Figure 2. Experimental murine melioidosis results in elevated OPN concentrations in plasma and lungs. OPN concentrations in (A)
plasma and (B) lung before, 24 and 72 h after intranasal infection with 10
3 CFU of B. pseudomallei. Data are expressed as means 6 SEM; n=8 mice/
group, * P,0.05, ** P,0.01 and *** P,0.001 as compared to t=0. OPN concentrations in culture supernatants after incubation of (C) MH-S and (D)
MLE-15 cells with medium or heat-killed B. pseudomallei (MOI 1:10 and 1:100) for 4 h. Data are expressed as means 6 SEM; n=4/group, * P,0.05 as
compared to medium stimulation.
doi:10.1371/journal.pntd.0000806.g002
Figure 3. Decreased pulmonary bacterial growth in OPN KO mice. WT (black bars) and OPN KO (white bars) mice were infected intranasally
with 10
3 CFU of B. pseudomallei and bacterial loads were determined 24 and 72 h after infection in (A) lung, (B) blood, and (C) spleen. Data are
expressed as means 6 SEM; n=8 mice/group, ** P,0.01 as compared to WT mice. N.D. means not detectable.
doi:10.1371/journal.pntd.0000806.g003
Osteopontin in Melioidosis
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shown).
Osteopontin contributes to pulmonary inflammation
To study the influence of OPN on pulmonary inflammation
during melioidosis, lung histology slides obtained 24 and 72 h after
infection were semi-quantitatively scored as described in the
Methods section. In both WT and OPN KO mice pulmonary
inflammation was characterized by significant interstitial inflam-
mation, pleuritis, bronchitis, endothelialitis and edema, which
increased from 24 to 72 h after infection. At the later time-point
necrotic lesions could also be found. Lung inflammation scores
were similar in both groups at 24 h after infection (figure 4A–C).
At 72 h, however, lungs from OPN KO mice demonstrated
significantly decreased inflammation scores as compared to WT,
which was especially due to less necrotic tissue (P,0.01, figure 4D–
G). In addition, OPN KO mice showed significantly reduced
percentages of affected lung parenchyma (figure 4H). As
neutrophils are the predominant infiltrating inflammatory cells
during melioidosis [12], we also measured MPO in lungs from WT
and OPN KO mice at 24 and 72 h after infection; MPO levels
increased from 24 to 72 h in both groups. In accordance with the
results on reduced percentages of affected lung, we found a trend
towards reduced MPO levels in OPN KO lungs at 24 h (P=0.10)
and significantly diminished MPO levels in OPN KO lungs at
72 h after infection (figure 4I, P,0.05).
Osteopontin does not influence hepatocellular injury
during melioidosis
Our model of melioidosis is associated with hepatocellular
injury [9,31]. To establish the role of OPN in this process we semi-
quantitatively scored liver histology slides obtained from WT and
OPN KO mice 24 or 72 h after infection. At 24 h post infection,
liver histology was unremarkable in both groups (data not shown).
At 72 h, both WT and OPN KO mice displayed abscesses,
necrosis and thrombus formation (figure 5A and B); pathology
scores were not different between groups (figure 5C). Consistent
with this was the finding that plasma levels of ALAT and ASAT
were similar in WT and OPN KO mice at this time point
(figure 5D–E).
Osteopontin impacts on mortality due to severe
melioidosis
To determine whether OPN affected mortality due to severe
melioidosis, we followed WT and OPN KO mice for two weeks
after B. pseudomallei infection. Consistent with reduced bacterial
outgrowth and diminished pulmonary tissue injury in OPN KO
mice, OPN deficiency had a positive effect on survival. Whereas
WT mice showed a median survival time of 95 h, OPN KO mice
had a median survival time of 118 h (P,0.05, figure 6).
Discussion
In this study we sought to determine the role of OPN in the
immune response to melioidosis. We demonstrate that plasma
concentrations of OPN are elevated in patients with severe
melioidosis and that high OPN levels on admission are correlated
with mortality. In experimental murine melioidosis, OPN did not
impact on the early host response; however, after 72 hours of
infection OPN KO mice displayed reduced bacterial growth in
lungs, accompanied by diminished pulmonary tissue injury and
associated with delayed mortality. Taken together, these data
suggest that enhanced production of OPN impairs host defense
during established septic melioidosis.
Recently, serum levels of OPN were reported to be elevated in
patients with sepsis caused by a mixture of pathogens and
originating from various infectious sources [28]. The present study
confirms and expands these data in a more homogenous cohort of
patients with sepsis caused by a single pathogen, B. pseudomallei.
Similar to a previous clinical study [28], we found that recovery
from the acute phase was accompanied by a reduction in
circulating OPN concentrations and that non-surviving patients
had higher OPN levels on admission. Humans usually acquire
melioidosis by inoculation through skin abrasions or inhalation,
and pneumonia with bacterial dissemination to distant body sites is
a common presentation of melioidosis [2,3]. We therefore used a
model of melioidosis in which mice were infected with B.
pseudomallei via the airways. Using this model we confirmed
increased release of OPN in the circulation and the lungs in mice
and identified alveolar macrophages and respiratory epithelial cells
as potential cellular sources for OPN upon infection with B.
pseudomallei. Enhanced OPN production is not likely to be
restricted to bacterial infections: elevated circulating OPN levels
have previously been reported in patients with mycobacterial and
fungal infections [35–38].
OPN has been shown to act as a chemo-attractant for several
immune cells including macrophages, neutrophils and T cells [20–
22,39]. In particular, extracellular OPN is chemotactic towards
neutrophils in vitro and in vivo, and the absence of intracellular
OPN impairs migration speed and polarization upon N-formyl
methionyl leucyl phenylalanine (fMLP) [22]. Considering that
recruitment of neutrophils to the site of infection is critical for
resistance against infection with B. pseudomallei [12], we anticipated
that OPN KO mice would display a reduced resistance against
experimentally induced melioidosis, especially since OPN may also
contribute to a protective Th1 response during infection.
However, whereas bacterial loads at 24 hours after infection were
similar in OPN KO and WT mice, at 72 h post infection OPN
deficiency was associated with an attenuated growth of B.
pseudomallei in lungs and a tendency towards reduced dissemina-
tion. These findings were paralleled by an absence of an effect of
endogenous OPN on the early recruitment of neutrophils into lung
tissue, as reflected by histopathology and similar levels of MPO in
whole lung homogenates from WT and OPN KO mice 24 h after
infection. Of note, very recent data indicate that pneumonia
Table 1. Pulmonary cytokine concentrations.
24h 72h
ng/mL WT OPN KO WT OPN KO
IL-12p70 0.08560.010 0.09960.017 0.17860.025 0.30460.053
IFN-c 0.06760.008 0.12960.074 0.21360.019 0.23560.013
TNF-a 0.531685.80 0.36960.140 6.38960.738 4.59560.860
IL-6 2.86760.412 3.40660.927 29.6667.791 29.89610.93
IL-10 0.22660.028 0.25960.006 0.60460.106 0.60760.088
KC 33.6164.47 18.4263.105* 262.2626.85 166.8626.31*
MIP-2 6.58160.522 6.28661.303 265.7626.56 244.8614.67
LIX 11.1960.801 13.0760.886 40.2064.522 40.9965.958
MCP-1 4.68060.450 2.87360.954 72.7468.493 85.53629.98
Proinflammatory cytokine (IL-12p70, IFN-c,T N F - a and IL-6), anti-inflammatory
IL-10 and chemokine (MIP-2, KC, LIX and MCP-1) levels in lung at 24 and 72 h
after intranasaal B. pseudomallei infection in WT and OPN KO mice. Data are
expressed as means 6 SEM; n=8 mice/group/time point. * P,0.05 vs. WT at
the same time point.
doi:10.1371/journal.pntd.0000806.t001
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www.plosntds.org 5 August 2010 | Volume 4 | Issue 8 | e806Figure 4. Reduced lung pathology in OPN KO mice. Representative lung pathology of WT (A, D) and OPN KO (B, E) mice 24 (A–C) and 72 (D–F)
h after intranasal infection with 10
3 CFU of B. pseudomallei. (G) Necrosis score and (H) the percentage of the inflamed area of the lung. (I)
Myeloperoxidase levels in lung homogenates at 24 and 72 h after infection. The lung sections are representative for 8 mice per group per timepoint.
H&E staining, original magnification 106. Quantitative data are expressed as means 6 SEM of 8 mice per group. * P,0.05 and ** P,0.01 as compared
to WT.
doi:10.1371/journal.pntd.0000806.g004
Figure 5. OPN does not influence hepatocellular injury. Representative liver pathology of WT (A) and OPN KO (B) mice 72 h after intranasal
infection with 10
3 CFU of B. pseudomallei. (C) Liver pathology scores (D) ALAT and (E) ASAT levels were similar at 72 h post infection. The liver sections
are representative for 8 mice per group per timepoint. H&E staining, original magnification 106. Quantitative data are expressed as means 6 SEM of
8 mice per group.
doi:10.1371/journal.pntd.0000806.g005
Osteopontin in Melioidosis
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pathogen, results in a brisk rise in pulmonary OPN levels in WT
mice and a diminished early neutrophil recruitment into the
pulmonary compartment of OPN KO mice [30]. Together, these
data suggest that the influence of endogenous OPN on neutrophil
influx to the site of infection at least in part depends on the
pathogen and its capacity to induce the local production of this
mediator. At 72 h after infection, pulmonary OPN levels were still
elevated, which together with the higher bacterial load might have
contributed to the increased neutrophil numbers in lungs of WT
mice; in addition, although early neutrophil recruitment is
essential for resistance to B. pseudomallei infection [12], neutrophils
can act as a ‘‘double-edged sword’’ and damage the architecture of
lung tissue [40,41], a mechanism that likely contributed to the
enhanced lung injury in WT mice. Indeed, many studies have
provided evidence for a crucial role of neutrophils in lung injury
[42,43]. Directly demonstrating such a detrimental role for
neutrophils in melioidosis may be difficult, considering that
neutrophil depletion results in much higher bacterial loads,
thereby hampering direct comparison with the host with normal
neutrophil counts [12]; in light of the fact that neutrophils are not
the only cells contributing to lung injury it can be anticipated that
the very high bacterial loads in neutrophil depleted mice cause
lung injury by mechanisms that do not rely on neutrophils. On the
other hand, the increased tissue necrosis in WT lungs may have
facilitated the local growth of B. pseudomallei by providing a niche
for this pathogen to escape killing by immune cells.
In previous studies, our laboratory demonstrated a link between
an impaired early neutrophil influx (at 24 hours post infection) and
a subsequently increased bacterial growth in MyD88 KO and
urokinase type plasminogen activator receptor KO mice infected
with B. pseudomallei [31,44]. Our current data are not inconsistent
with these earlier findings: early neutrophil influx (24 hours) did
not differ between OPN KO and WT mice, whereas the fact that
at 72 hours after infection lung MPO levels were lower in OPN
KO mice likely was the consequence of the lower bacterial loads
(providing a less potent chemotactic stimulus), possibly in
combination with lower lung levels of the neutrophil chemoat-
tractant KC.
In the last decade, numerous in vitro and in vivo studies have
proposed OPN as an important player in Th1 responses [24–
27,45]. For example, OPN induces IL-12 release by murine
peritoneal macrophages, whereas OPN prevents lipopolysaccha-
ride induced production of the Th2 cytokine IL-10 [24].
Moreover, T-cell dependent IL-12 production by human
peripheral blood mononuclear cells is enhanced by OPN, in part
via its ability to regulate CD3-induced expression of IFN-c and
CD40L by T-cells [25]. In addition, OPN has been shown to
contribute to Th1 responses in vivo, including experimental
autoimmune encephalomyelitis, infection with herpes simplex
virus-1 and with Plasmodium chabaudi chabaudi [24,26,27]. Consid-
ering that Th1 cytokines serve a protective role in the immune
response to experimental melioidosis [9–11], we anticipated that
OPN deficiency would result in an impaired host defense response
due to an attenuated induction of protective Th1 cytokines.
However, we found no significant differences in the levels of the
Th1 cytokines IL-12 and IFN-c between WT and OPN KO mice
at any timepoint. In this respect, it should be noted that in a model
of murine tuberculosis we also did not detect an effect of OPN on
the Th1 response [29]. Similarly, normal immune responses of
OPN KO mice have been reported during vaccinia virus,
influenza virus, Listeria monocytogenes [46] and Borrelia burgdorferi
infection [47,48]. With regard to murine melioidosis it should be
noted that natural killer cells, rather than T cells, are the main
producers of IFN-c [12]. In our model of melioidosis OPN did not
impact on the release of other cytokines and chemokines with
exception of KC, which was lower in OPN KO mice.
OPN deficiency did not impact on hepatocellular injury after
infection with B. pseudomallei. OPN can be produced in the liver by
various cell types, including Kupffer cells, macrophages, hepatic
stellate and epithelial cells [49,50]. Hepatic OPN has been
implicated as a mediator of several forms of sterile liver injury,
including T cell mediated hepatitis [51], acetaminophen-induced
hepatic injury [52], nonalcoholic steatohepatitis [53] and carbon
tetrachloride induced liver injury [54]. In contrast to these models,
hepatocellular injury during experimental melioidosis is not caused
by a direct toxic hepatic insult. Rather, liver damage is the result of
dissemination of B. pseudomallei to distant organs and as a
consequence thereof tissue damage. In a previous study, our
laboratory demonstrated a link between the extent of bacterial
dissemination and hepatocellular injury during murine melioidosis
[33]. In the present study, bacterial loads in spleen and blood did
not differ between OPN KO and WT mice. Together these data
indicate that although OPN facilitates several forms of sterile
hepatocellular injury, it does not play a role of importance in liver
damage during septic melioidosis.
The latest sampling time point (72 hours) was chosen since the
first deaths occurred shortly thereafter. Considering that WT mice
displayed an accelerated mortality, comparisons between OPN
and WT mice beyond 72 hours would be biased due to the fact
that the most severely ill mice already had died.
OPN has been implicated in a variety of immune responses
considered to contribute to an adequate host defense against
invading pathogens. Here, we show that the production of OPN is
enhanced during clinical and experimental melioidosis. Whereas
endogenous OPN did not impact on the early host response during
melioidosis in mice, its sustained release hampered the local
control of the infection as reflected by reduced bacterial growth in
lungs, less pulmonary inflammation and a delayed mortality in
OPN KO mice. These data suggest that OPN plays a detrimental
role in established sepsis caused by B. pseudomallei infection
originating from the lung.
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